Literature DB >> 6087659

Changing patterns of hospital infections: implications for therapy. Changing mechanisms of bacterial resistance.

H C Neu.   

Abstract

During the past decade there has been a marked increase in resistance of bacteria to antimicrobial agents. Microorganisms have developed the ability to make altered receptors for antimicrobial agents, have prevented agents from reaching their receptors within the bacterial cell, now have enzymes to destroy antibiotics, and have resistant metabolic pathways. Altered penicillin receptors, penicillin-binding proteins, have been found in Streptococcus pneumoniae, Streptococcus faecalis, Staphylococcus aureus, Neisseria gonorrhoeae, Clostridium, and Pseudomonas aeruginosa. Resistance based on decreased entry of drugs has been found for penicillins, cephalosporins, aminoglycosides, and tetracyclines in the Enterobacteriaceae and Pseudomonas aeruginosa. Beta-lactamase resistance has increased significantly being encountered in Neisseria, Haemophilus, Enterobacteriaceae, and Pseudomonas species. Chromosomal inducible beta-lactamases, which function as cephalosporinases, have been a particular problem in Enterobacter and Citrobacter species, and organisms resistant to the third-generation cephalosporins have been isolated from patients. It is clear that beta-lactamases and changes in cell wall permeability will play an extremely important role in the future of the new penicillins and cephalosporins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087659

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Serum bactericidal test.

Authors:  C W Stratton
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Comparison of epidemiologic markers for Staphylococcus epidermidis.

Authors:  J T Parisi; B C Lampson; D L Hoover; J A Khan
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

Review 3.  The biochemical basis of antimicrobial and bacterial resistance.

Authors:  H C Neu
Journal:  Bull N Y Acad Med       Date:  1987-04

4.  Outer membrane penetration by (2,3)-methylenepenams.

Authors:  J S Chapman; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

5.  Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial.

Authors:  M F Güneren
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 6.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.